Newsmeme!
Discover News you didn't know existed
Emerging Infectious Diseases
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Editorials, Opinion Pieces Respond To World AIDS Day
Published December 2, 2008, 9:11 am, Medical News Today
Several newspapers have published editorials and opinion pieces in response to World AIDS Day. Summaries appear below.EditorialsArizona Daily Star: World AIDS Day is a "good time to issue a wake-up call," a Daily Star editorial says, adding, "This scourge has not gone away. It still cannot be cured. No one is known to be immune.
Southern Research Wins $37 Million Black & Veatch Sub-Contract for Biological Threat Reduction Program
Published December 2, 2008, 8:14 am, PR Newswire via Yahoo! News
Southern Research Institute a not-for-profit scientific organization that conducts basic and applied research in the areas of preclinical drug discovery and development, advanced engineering, environmental and energy production today announced that it has been awarded a subcontract from Black & Veatch to help support the U.S. Department of Defense's Biological Threat Reduction Program (BTRP) in ...
PolyMedix Appoints New Vice President of Business Development
Published December 2, 2008, 6:16 am, Centre Daily Times
PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com ), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has appointed J. Gregory Ford as its new Vice President of Business Development.
PolyMedix Appoints New Vice President of Business Development
Published December 2, 2008, 5:30 am, Business Wire via Yahoo! Finance
RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, has appointed J.
Rudolph NSX Selected for Inspection and Metrology of New Through-Silicon Via Process
Published December 2, 2008, 4:17 am, Centre Daily Times
Rudolph Technologies, Inc. (NASDAQ: RTEC), a worldwide leader in process characterization solutions for the semiconductor manufacturing industry, announced today the successful installation of an NSX ® 115 Macro Inspection System at a major European fab. The NSX is being used for high-volume inspection and metrology of next-generation production processes, including through-silicon vias ...
Rudolph’s New Explorer Macro Defect Inspection System Gains Traction with Low Cost-of-Ownership
Published December 2, 2008, 4:17 am, Centre Daily Times
Rudolph Technologies, Inc. (NASDAQ: RTEC), a worldwide leader in process characterization solutions for the semiconductor manufacturing industry, today announced the shipment of its new Explorer ™ Inspection Cluster to a major chip manufacturer located in Japan.
Rudolph NSX Selected for Inspection and Metrology of New Through-Silicon Via Process
Published December 2, 2008, 4:00 am, Business Wire via Yahoo! Finance
TOKYO----Rudolph Technologies, Inc. , a worldwide leader in process characterization solutions for the semiconductor manufacturing industry, announced today the successful installation of an NSX® 115 Macro Inspection System at a major European fab.
World’s Fastest Animal, In Race For Survival
Published December 1, 2008, 3:08 pm, Scoop.co.nz
The critically endangered cheetah, the world’s fastest land animal, is set to obtain added international protection next week at a United Nations-backed conference seeking to strengthen conservation of species that often cross national borders.
World AIDS Day 2008: Much accomplished, much to do
Published December 1, 2008, 1:51 pm, CNN
When we commemorated the first World AIDS Day on December 1, 1988, we had little to celebrate.
First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model
Published December 1, 2008, 12:10 pm, Medical News Today
Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover, develop, and commercialize microRNA-based therapeutics, announced today the publication of new research in the journal Nature on the role of a microRNA, known as miR-21, in heart failure(1).
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |